Abbott reports positive Simcor trial results

11/4/2007 | CNNMoney

Abbott Laboratories' cholesterol-lowering treatment Simcor significantly reduced "bad" LDL cholesterol and improved "good" HDL cholesterol compared to simvastatin during its Phase III clinical trial. The company hopes to get regulatory approval for Simcor, a combination of simvastatin and another drug from Abbott, during the first quarter of 2008.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care